$PYPD
$4.47
-$0.07 (1.54%)
Overview
$PYPD Overview
Financials
SEC Filings
Executives
News
Specialized Tools
Valuations
P
Insider Transactions
P
Congressional Trades
P
PolyPid Ltd
polypid.comPolyPid Ltd. operates as a phase 3 biopharma company. The company is headquartered in Petah Tikva, Central(Hamerkaz) and currently employs 69 full-time employees. The company went IPO on 2020-06-26. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Financial Snapshot
Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$33.63M
Current Assets
2026 Q1
$12.56M
Current Liabilities
2026 Q1
$7.048M
Current Ratio
2026 Q1
178.21%
Total Assets
2026 Q1
$19.16M
Total Liabilities
2026 Q1
$10.38M
Book Value
2026 Q1
8.780M
Cash
2026 Q1
$8.888M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$28.09M
Loading...
